Skip to main content

Advertisement

Open Peer Review Reports for: Safety and effectiveness of adalimumab in a clinical setting that reflects Canadian standard of care for the treatment of rheumatoid arthritis (RA): Results from the CanACT study

Back to article

Pre-publication versions of this article are available by contacting info@biomedcentral.com.

Original Submission
29 Jun 2011 Submitted Original manuscript
15 Jul 2011 Reviewed Reviewer Report - Bernhard Manger
24 Jul 2011 Reviewed Reviewer Report - Rudolf Puchner
9 Sep 2011 Author responded Author comments - Boulos Haraoui
Resubmission - Version 2
9 Sep 2011 Submitted Manuscript version 2
16 Sep 2011 Author responded Author comments - Boulos Haraoui
Resubmission - Version 3
16 Sep 2011 Submitted Manuscript version 3
Resubmission - Version 4
Submitted Manuscript version 4
16 Nov 2011 Author responded Author comments - Boulos Haraoui
Resubmission - Version 5
16 Nov 2011 Submitted Manuscript version 5
Publishing
17 Nov 2011 Editorially accepted
17 Nov 2011 Article published 10.1186/1471-2474-12-261

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting info@biomedcentral.com.

You can find further information about the peer review system here.

Advertisement